retatrutide glucagon receptor vs. Ozempic: The Triple Agonist That May Change Everything., Semaglutide hits one receptor. Retatrutide hits three., That difference may be the biggest leap in metabolic medicine since , Retatrutide | GLP-1R/GIPR/GCGR ligand |
Description
GLP-1s & NAION
Skipping one dose occasionally won't derail your progress, though consistent weekly dosing produces the best results
Cell Metab 26:278
It is most potent at the GIP receptor (EC50 of 0.0643 nM), moderately potent at GLP-1 (EC50 of 0.775 nM), and least potent at the glucagon receptor (EC50 of 5.79 nM)
For lab use only
But none had been isolated with incretin-like properties first described by La Barre which was considered to be ideal for the treatment of type 2 diabetes (Marks Samols
